Immuron Ltd
IMM-529
Clostridioides difficile infection
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on IMM-529 for Clostridioides difficile infection is expected Date TBD.
Primary source
· SEC 6-K
verified 14h ago
“FDA approval of IMM-529 Investigational New Drug application for Phase 2 clinical trial in Clostridioides difficile infection”